58754-46-4
58754-46-4 structure
- Name: (E)-N-[2-[2-[(2S)-1-methyl-2-piperidyl]ethyl]phenyl]-3-phenyl-prop-2-e namide
- Chemical Name: iferanserin
- CAS Number: 58754-46-4
- Molecular Formula: C23H28N2O
- Molecular Weight: 348.48100
- Catalog: Signaling Pathways GPCR/G Protein 5-HT Receptor
- Create Date: 2016-12-04 16:53:49
- Modify Date: 2024-01-09 15:59:31
-
Iferanserin (S-MPEC) is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment[1].
| Name | iferanserin |
|---|
| Description | Iferanserin (S-MPEC) is a selective 5-HT receptor (serotonin receptor) antagonist with an affinity for 5-HT2A receptor. Iferanserin has the potential for internal hemorrhoid disease treatment[1]. |
|---|---|
| Related Catalog | |
| Target |
5-HT2A Receptor |
| In Vitro | An intra-anal ointment application of Iferanserin might modify the vascular effects occurring in hemorrhoid disease and thereby reduce or eliminate the most frequently occurring symptoms of hemorrhoid disease[1]. |
| References |
| Density | 1.096g/cm3 |
|---|---|
| Boiling Point | 536.4ºC at 760 mmHg |
| Molecular Formula | C23H28N2O |
| Molecular Weight | 348.48100 |
| Flash Point | 278.2ºC |
| Exact Mass | 348.22000 |
| PSA | 32.34000 |
| LogP | 4.76630 |
| Index of Refraction | 1.61 |
|
~%
58754-46-4 |
| Literature: SAM AMER and CO., INC.; AMER, Moh, Samir Patent: WO2012/26914 A1, 2012 ; Location in patent: Page/Page column 13 ; WO 2012/026914 A1 |
|
~%
58754-46-4 |
| Literature: SAM AMER and CO., INC.; AMER, Moh, Samir Patent: WO2012/26914 A1, 2012 ; WO 2012/026914 A1 |
|
~%
58754-46-4 |
| Literature: SAM AMER and CO., INC.; AMER, Moh, Samir Patent: WO2012/26914 A1, 2012 ; WO 2012/026914 A1 |
|
~%
58754-46-4 |
| Literature: SAM AMER and CO., INC.; AMER, Moh, Samir Patent: WO2012/26914 A1, 2012 ; WO 2012/026914 A1 |
